Unresectable Malignant Solid Neoplasm

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB11740	Adavosertib	1	Active Not Recruiting	1
DB11595	Atezolizumab	1	Active Not Recruiting	1
DB18028	Azenosertib	1	Not Yet Recruiting	1
DB11105	Benzalkonium	1	Recruiting	1
DB11794	Berzosertib	1	Active Not Recruiting	1
DB11967	Binimetinib	1	Recruiting	1
DB04690	Camptothecin	1	Active Not Recruiting	2
DB01101	Capecitabine	1	Recruiting	1
DB00958	Carboplatin	1	Completed	1
DB04849	Cediranib	1	Active Not Recruiting	1
DB14707	Cemiplimab	1	Terminated	1
DB14917	Ceralasertib	1	Recruiting	1
DB12483	Copanlisib	1	Active Not Recruiting	2
DB00531	Cyclophosphamide	1	Recruiting	1
DB15627	Dostarlimab	1	Recruiting	1
DB11714	Durvalumab	1	Active Not Recruiting	1
DB15631	Edodekin alfa	1	Active Not Recruiting	1
DB15127	Hydrogen	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Active Not Recruiting	1
DB00762	Irinotecan	1	Active Not Recruiting	2
DB15721	Natural Killer Cell	1	Active Not Recruiting	1
DB16252	Nedisertib	1	Recruiting	1
DB11793	Niraparib	1	Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB01051	Novobiocin	1	Suspended	1
DB09074	Olaparib	1	Active Not Recruiting	2
DB09074	Olaparib	1	Completed	1
DB09074	Olaparib	1	Recruiting	1
DB06306	Onalespib	1	Completed	1
DB01229	Paclitaxel	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Completed	1
DB09037	Pembrolizumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Recruiting	2
DB17864	SAR-439459	1	Terminated	1
DB00020	Sargramostim	1	Recruiting	1
DB11689	Selumetinib	1	Active Not Recruiting	1
DB09143	Sonidegib	1	Recruiting	1
DB17285	Sulanemadlin	1	Active Not Recruiting	1
DB14546	Sulfate ion	1	Active Not Recruiting	1
DB11760	Talazoparib	1	Completed	1
DB01030	Topotecan	1	Active Not Recruiting	1
DB14962	Trastuzumab deruxtecan	1	Active Not Recruiting	1
DB14962	Trastuzumab deruxtecan	1	Not Yet Recruiting	1
DB14962	Trastuzumab deruxtecan	1	Recruiting	2
DB11945	Avelumab	1 / 2	Active Not Recruiting	1
DB11794	Berzosertib	1 / 2	Active Not Recruiting	1
DB12483	Copanlisib	1 / 2	Active Not Recruiting	1
DB08912	Dabrafenib	1 / 2	Active Not Recruiting	1
DB06186	Ipilimumab	1 / 2	Active Not Recruiting	1
DB15994	Methane	1 / 2	Active Not Recruiting	1
DB12340	Navitoclax	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Active Not Recruiting	1
DB09037	Pembrolizumab	1 / 2	Terminated	1
DB11759	Pevonedistat	1 / 2	Terminated	1
DB08911	Trametinib	1 / 2	Active Not Recruiting	2
DB11969	Uprosertib	1 / 2	Active Not Recruiting	1
DB17500	Vidutolimod	1 / 2	Terminated	1
DB12015	Alpelisib	2	Recruiting	1
DB11967	Binimetinib	2	Recruiting	1
DB00544	Fluorouracil	2	Recruiting	1
DB00947	Fulvestrant	2	Recruiting	1
DB15127	Hydrogen	2	Recruiting	1
DB11743	Ipatasertib	2	Recruiting	2
DB00650	Leucovorin	2	Recruiting	1
DB11828	Neratinib	2	Recruiting	1
DB04868	Nilotinib	2	Recruiting	1
DB09074	Olaparib	2	Recruiting	1
DB00526	Oxaliplatin	2	Recruiting	1
DB01229	Paclitaxel	2	Recruiting	2
DB09073	Palbociclib	2	Recruiting	1
DB01269	Panitumumab	2	Recruiting	1
DB11689	Selumetinib	2	Recruiting	1
DB15569	Sotorasib	2	Recruiting	1
DB14546	Sulfate ion	2	Recruiting	1
DB11760	Talazoparib	2	Recruiting	1
DB15232	Telaglenastat	2	Active Not Recruiting	1